TheProfitWatch

PRFX - PainReform Ltd. Ordinary Shares

Day 1m 10m 60m PreMarket Market AfterHours Gap
0.86 0.0 (0.53%) 0.0 (0.0%) 0.0 (0.0%) 0.01 (0.63%) 0.0 (0.0%) 0.03 (3.32%) 0.0 (-0.01%) 0.0 (0.19%)

PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics. The company's product PRF-110 is based on the local anesthetic ropivacaine, targeting the post-operative pain relief market. PRF-110 is an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed before closure to provide localized and extended post-operative analgesia.

Category: /stock/categories/na
Market Period: PreMarket

Earnings & Ratios

Basic EPS:
Diluted EPS:
Basic P/E:
Diluted P/E:
RSI(14) 1m:
61.9
VWAP:
0.87
RVol:

Events

Period Kind Movement Occurred At

Related News